SAD-CP, a home-based palliative care program, was shown to effectively meet the care needs of patients with advanced cancer, particularly in underserved areas. A home-based palliative care program was ...

Significantly lower risks seen for those receiving GLP-1 receptor agonists compared with other antidiabetic drugs.

Use of glucagon-like peptide-1 receptor agonists might be beneficial for patients with some cancers, research suggests.

The survey was conducted in May 2025 online (978 participants) and by telephone (30 participants).

Weekend warrior and regular activity patterns meeting current recommendations associated with reduced all-cause, CVD mortality.

Obinutuzumab, a B-cell depleting therapy, is being explored for reducing lupus nephritis risks, such as flare.

The FDA has accepted the New Drug Application for ET-600, an oral solution formulation of desmopressin, for the treatment of central diabetes insipidus.

The first bladder transplant in a living patient is the successful result of years of research and surgical innovation.

A trial testing a nerve-sparing (NeuroSAFE) technique in radical prostatectomy may improve patient-reported outcomes.

GLP-1 receptor agonists linked to lower medication use and reduced headaches, visual disturbances or blindness, and papilledema.

Robot-assisted laparoscopic supratrigonal cystectomy with augmentation cystoplasty is feasible, with acceptable complication rates.

Childhood cancer survivors have a higher risk of developing severe COVID-19 than the general population, data suggest.